Evidence map›Paper›PMID 33595053›Full record

ArticleAmerican journal of epidemiology2021

Emulating Target Trials to Improve Causal Inference From Agent-Based Models.

Eleanor J Murray, Brandon D L Marshall, Ashley L Buchanan

Abstract read
In one paragraph

Article in American journal of epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Applications of agent-based modeling in trauma research.Psychological trauma : theory, research, practice and policy · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eleanor J Murray
Brandon D L Marshall
Ashley L Buchanan

Funding

Highly Adaptive Epidemic Control Strategies for HIV Prevention in Drug UsersDP2DA040236 · NIDA · BROWN UNIVERSITY · PI MARSHALL, BRANDON DAVID LEWIS · 2015 to 2015
$2.4M
Causal Inference Methods for HIV Prevention Studies Among Networks of People Who Use DrugsDP2DA046856 · NIDA · UNIVERSITY OF RHODE ISLAND · PI BUCHANAN, ASHLEY LYNN · 2018 to 2019
$2.3M
HPV vaccination efficacy for cervical cancer prevention in young women with perinatal HIV infectionR21HD098733 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MURRAY, ELEANOR · 2019 to 2020
$467k
NICHD NIH HHS R21 HD098733NIDA NIH HHS DP2 DA040236NIDA NIH HHS DP2 DA046856
6 · The paper itself

Abstract

Agent-based models are a key tool for investigating the emergent properties of population health settings, such as infectious disease transmission, where the exposure often violates the key "no interference" assumption of traditional causal inference under the potential outcomes framework. Agent-based models and other simulation-based modeling approaches have generally been viewed as a separate knowledge-generating paradigm from the potential outcomes framework, but this can lead to confusion about how to interpret the results of these models in real-world settings. By explicitly incorporating the target trial framework into the development of an agent-based or other simulation model, we can clarify the causal parameters of interest, as well as make explicit the assumptions required for valid causal effect estimation within or between populations. In this paper, we describe the use of the target trial framework for designing agent-based models when the goal is estimation of causal effects in the presence of interference, or spillover.

Indexed as

CausalityEpidemiologic StudiesResearch DesignSystems AnalysisConfounding Factors, EpidemiologicHumansModels, Statisticalagent-based modelscausal inferenceinterferencespillovertarget trials

Identifiers

PMID33595053
PMCPMC8484776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.